Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Halozyme Therapeutics, Inc. | StockGist | StockGist

Companies
HALO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings HALOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Halozyme Therapeutics, Inc.

Filed Mar 27, 2026

Accepted Mar 27, 2026, 9:33 AM ET

CIK 0001159036

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

HALOZYME THERAPEUTICS, INC.

Person Type

IA

Amendment History

3 filings

SCHEDULE 13G
Original
May 13, 20250000093751-25-000277
SCHEDULE 13G/A
Amendment 1
Jul 17, 20250002052113-25-003063
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Mar 27, 20260000102909-26-001483

Recent Filings

Halozyme Therapeutics, Inc.3 weeks ago

Halozyme Therapeutics, Inc.1 months ago

Halozyme Therapeutics, Inc.1 months ago

Halozyme Therapeutics, Inc.2 months ago

Halozyme Therapeutics, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice